Clinical trial reportNature communicationsPublished
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107
Regional connection
Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source
- Institution
- The Wistar Institute
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Nature communications
- Published
- Topic
- Clinical care
- Subject terms
- T-Lymphocytes; Humans; Respiratory Tract Infections; Papillomavirus Infections; Vaccines, DNA; Treatment Outcome; Immunotherapy; Adult; Aged; Middle Aged; Female; Male
- PubMed ID
- 39939590
- PubMed Central ID
- PMC11821913
- Open access
- Yes, open
- Added to directory
- Source checked